See the DrugPatentWatch profile for Valium
How much Valium is being sold, and where do sales show up?
“Valium” is the brand name for diazepam. Public reporting on Valium “sales” depends on the level of detail you need (for example: global vs. U.S. only, prescription-dispensing vs. manufacturer revenue). The most common places to track sales are:
- Prescription/dispensing datasets (often paywalled)
- Company financial disclosures for the manufacturer/brand owner
- Government or industry reports that break out benzodiazepine volumes and spending
If you tell me whether you mean U.S. prescriptions, worldwide sales, or the revenue of a specific manufacturer/brand owner, I can narrow what “Valium sales” should mean.
Is Valium still a major drug by sales, or has it declined?
Valium’s sales have been affected over time by tighter prescribing controls, substitution among benzodiazepines, and changes in product availability in some markets. To answer the question with numbers, you typically need a specific time window (for example, “annual U.S. sales in 2019–2023”) and a data source definition (revenue vs. units).
What companies sell Valium, and how can that affect “sales” numbers?
“Valium sales” can mean different things depending on who is selling it:
- Brand-owner revenue for the Valium product
- Licensee/wholesaler distribution revenue (if reported)
- Generic diazepam sales (often confused with “Valium” because patients and clinicians say “Valium” generically)
To avoid mixing brand and generic numbers, sales figures must specify “Valium (brand)” versus “diazepam (all products).”
How do patent and exclusivity issues change Valium sales?
Sales can shift dramatically once brand exclusivity ends because generic versions usually take share. For drug-specific market history and patent/exclusivity context, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
What if I meant “Valium” as in benzodiazepines—how does that compare?
If your real intent is “benzodiazepine market size” rather than one brand, then Valium is only one reference point. Benzodiazepine spend and volume can be compared across agents, but the headline figures depend heavily on the dataset (claims, pharmacy purchases, or wholesaler shipments).
Quick clarification so I can pull the right kind of sales
Which of these do you want?
1) Valium (brand) revenue/sales, U.S., by year
2) Valium (brand) prescription volume, U.S., by year
3) Worldwide Valium sales
4) Diazepam (all brands + generics) sales, not just Valium
5) A specific manufacturer’s Valium sales (name the company if you know it)
Reply with the option number and the date range (or “most recent year”), and I’ll tailor the answer to the exact “Valium sales” you’re looking for.